Valuation: Bioneer Corporation

Market Cap 151B 104M 91.44M 85.35M 78.33M 147M 9.97B 150M 1.01B 396M 4.93B 391M 382M 17.05B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 165B 114M 99.86M 93.21M 85.54M 160M 10.89B 164M 1.11B 432M 5.39B 427M 417M 18.62B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day-1.03%
1 week-3.82%
Current month-15.35%
1 month-17.76%
3 months-46.93%
6 months-59.05%
Current year-54.59%
1 week 5,470
Extreme 5470
6,690
1 month 5,470
Extreme 5470
7,100
Current year 5,470
Extreme 5470
14,210
1 year 5,470
Extreme 5470
15,640
3 years 5,470
Extreme 5470
47,700
5 years 5,470
Extreme 5470
98,800
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 01/08/1992
Corporate Officer/Principal 51 31/03/2025
Corporate Officer/Principal 62 28/03/2024
Director TitleAgeSince
Director/Board Member 64 18/02/2011
Director/Board Member 61 01/05/1997
Director/Board Member 63 01/02/2000
Date Insider Type Main position Quantity % Market Cap.
6/12/25 A Fiscal year

Director

2,625 0.0102%
3/3/25 A Buy

Chief Executive Officer

3,000 0.0116%
1/22/25 A Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-3.82%-61.37%-86.63% 104M
-3.74%-6.32%+42.70%+63.37% 55.2B
-0.81%-0.33%+27.15%+81.12% 55.6B
-0.73%+0.97%-15.54%-14.62% 23.51B
-3.21%-6.19%-4.20%+356.16% 22.35B
-4.01%-2.68%+12.50%-12.70% 20.6B
-1.23%-3.15%+26.00%-33.84% 17.45B
-3.34%-6.96%+22.02%+515.48% 15.16B
-0.53%-1.09%+49.36%+179.27% 13.91B
-5.09%-13.14%+151.85%+272.20% 13.74B
Average -2.32%-2.32%+25.05%+131.98% 23.76B
Weighted average by Cap. -2.36%-0.46%+30.38%+121.26%

Financials

2024 2025
Net sales 294B 203M 178M 166M 153M 285M 19.41B 293M 1.97B 771M 9.6B 761M 744M 33.2B 330B 228M 200M 187M 171M 321M 21.79B 328M 2.21B 865M 10.78B 854M 836M 37.28B
Net income -20.58B -14.19M -12.47M -11.64M -10.68M -19.99M -1.36B -20.48M -138M -53.96M -672M -53.26M -52.11M -2.32B -2.81B -1.94M -1.7M -1.59M -1.46M -2.73M -186M -2.8M -18.86M -7.37M -91.9M -7.28M -7.12M -318M
Net Debt -20.54B -14.15M -12.44M -11.61M -10.65M -19.95M -1.36B -20.44M -138M -53.84M -671M -53.14M -51.99M -2.32B 13.9B 9.58M 8.42M 7.86M 7.21M 13.5M 917M 13.83M 93.16M 36.43M 454M 35.96M 35.18M 1.57B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
392
Date Price Change Volume
30/07/26 5,790.00 -1.03% 74,477
29/07/26 ₩5,850.00 -6.55% 141,791
28/07/26 ₩6,260.00 -3.54% 46,319
27/07/26 ₩6,490.00 +1.72% 42,526
24/07/26 ₩6,380.00 -0.31% 44,605
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock